Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-06-06
1997-05-13
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514340, 514343, 546193, 546194, 5462681, 5462764, C07D40102, A61K 3144
Patent
active
056293259
ABSTRACT:
Novel 3-pyridyloxymethyl heterocyclic ether compounds of the formula: ##STR1## or the pharmaceutically-acceptable salts or prodrugs thereof are selective and potent ligands at neuronal nicotinic cholinergic channel receptors, and are effective in controlling synaptic transmission.
REFERENCES:
patent: 4592866 (1986-06-01), Cale, Jr.
patent: 4643995 (1987-02-01), Engel et al.
patent: 4889864 (1989-12-01), Ehrhardt et al.
patent: 4946836 (1990-08-01), Engel et al.
patent: 4956359 (1990-09-01), Taylor, Jr. et al.
patent: 5037841 (1991-08-01), Schohe et al.
patent: 5278176 (1994-01-01), Lin
patent: 5472958 (1995-12-01), Gunn, Jr. et al.
Abreo et al, J. Med. Chem., vol. 39, No. 4, 1996, 817-25 (Chem. Abstract 124:232,204).
He Yun
Holladay Mark W.
Li Yihong
Lin Nan-Horng
Ryther Keith
Abbott Laboratories
Browder Monte R.
Davis Zinna Northington
LandOfFree
3-pyridyloxymethyl heterocyclic ether compounds useful in contro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-pyridyloxymethyl heterocyclic ether compounds useful in contro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-pyridyloxymethyl heterocyclic ether compounds useful in contro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385624